- KILITCH DRUGS
KILITCH DRUGS Share Price
NSE: KILITCH
|BSE: 524500
|Pharmaceuticals
₹454.50
-₹0.05 (-0.01%) Last updated on 13 Jun, 2025 | 15:53 ISTKILITCH DRUGS Overview
Market cap  ₹731 Crs | Open ₹440.00 | Prev. Close ₹454.55 |
Circuit range ₹477.20 - ₹431.80 | Day range ₹433.30 - ₹459.90 | Year range ₹299.95 - ₹499.00 |
Volume 10,070 | Avg. traded ₹449.20 | Revenue (12m) ₹198 Crs |
About KILITCH DRUGS
Kilitch Drugs (India) Limited is an India-based pharmaceutical manufacturing company. The Company is mainly engaged in the development and operations of the pharmaceutical business. Its services range from manufacturing to marketing a host of formulations in all dosage forms. The Company offers products in the categories of Parenteral and Nasal Products, Oral, Effervescent, Nutritional Products, Medical Devices, and Cosmetics and Herbal Products. It offers products that help in gastroenterology, anti-inflammatory, anti-malaria, diagnostics, uterine stimulants, veterinary and many more areas in the form of ampoules & vials. Its range of oral formulations includes tablets, capsules, dry syrups and oral powders. It provides a range of cosmetics ranging from oil, lotion, liquid to cream and paste in the skin care, personal care and hair care categories. It offers a medical device, namely, the C-Seal. ROIPAR, ROIVIT, PH-7, C-SEAL, SRO-KIT, 9-VIT, HPURE are their product offerings.
KILITCH DRUGS Share Price Chart
Please wait...
KILITCH DRUGS Key Indicators
P/E ratio 27.76 | P/B ratio 3.48 | ROE 8.51% |
ROCE 10.75% | Dividend yield -- | Debt/Equity ratio 0.14 |
EPS 10.93 |
Investment Checklist: (4/6)
Equity returns
Dividend returns
Safety factor
Growth factor
Debt vs Equity
Profit factor
The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily
Analyst Ratings:
100%
Hold
0%
Sell
0%
This analysis is based on the reviews of 1 experts in the last 7 days
KILITCH DRUGS Financial Ratios
Operating profit margin20.22% | Net profit margin13.35% |
ROE8.51% | ROA6.57% |
ROCE10.75% |
Quick ratio2.14 | Current ratio2.2 |
Interest coverage12.59 | Asset turnover0.49 |
Debt to Equity0.14 |
P/E ratio27.76 | P/B ratio3.48 |
EV / EBITDA24.04 | |
Dividend yield0% |
Revenue Statement
All values are in ₹ Crores (Cr)
Year  | Revenue  | Operating Profit | Net Profit |
|---|---|---|---|
Mar-24 | ₹154.37 | ₹28.74 | ₹13.58 |
Mar-23 | ₹139.60 | ₹20.65 | ₹8.28 |
Mar-22 | ₹114.23 | ₹13.41 | ₹6.21 |
Mar-21 | ₹68.52 | ₹7.98 | ₹3.77 |
Cash Flow
All values are in ₹ Crores (Cr)
Year | Operating | Investing | Financing |
|---|---|---|---|
Mar-24 | ₹-0.15 | ₹-9.54 | |
Mar-23 | ₹-0.72 | ||
Mar-22 | ₹-15.25 | ||
Mar-21 | ₹-37.57 |
Balance Sheet
All values are in ₹ Crores (Cr)
Period | Total Asset | Total Liability |
|---|---|---|
Mar-24 | ₹237.50 | ₹61.82 |
Mar-23 | ₹217.54 | ₹66.96 |
Mar-22 | ₹208.34 | ₹68.04 |
Mar-21 | ₹201.90 | ₹72.42 |
KILITCH DRUGS Share Price History
| Day | Open | Close | Change % |
|---|---|---|---|
13-Jun-25 | ₹440.00 | ₹454.50 | -0.01% |
12-Jun-25 | ₹460.00 | ₹454.55 | -0.10% |
11-Jun-25 | ₹457.90 | ₹455.00 | |
10-Jun-25 | ₹449.90 | ₹452.95 | |
09-Jun-25 | ₹457.00 | ₹442.55 | -0.33% |
06-Jun-25 | ₹443.10 | ₹444.00 | |
05-Jun-25 | ₹424.95 | ₹443.10 | |
04-Jun-25 | ₹422.65 | ₹422.00 | -0.15% |
Stocks Similar to KILITCH DRUGS
Stock Name | Price | Change % |
|---|---|---|
| Albert David | ₹863.90 | +₹3.30 (0.38%) |
| BAFNA PHARMA | ₹75.00 | +₹1.88 (2.57%) |
| FREDUN PHARMACEUTICALS LIMITED | ₹815.00 | +₹15.60 (1.95%) |
| JENBURKT PHARMACEUTICALS LTD | ₹1,324.00 | +₹42.05 (3.28%) |
| Lasa Supergenics | ₹12.52 | -₹0.66 (-5.01%) |
| Sakar Healthcare | ₹312.90 | +₹0.30 (0.10%) |
| SMRUTHI ORGANICS LIMITED | ₹123.05 | -₹3.80 (-3%) |
| WANBURY LIMITED | ₹312.20 | +₹11.60 (3.86%) |
Popular Stocks
Stock Name | Price | Change % |
|---|---|---|
| IDFC First Bank | ₹70.44 | -₹0.41 (-0.58%) |
| Indian Oil Corp | ₹140.34 | -₹2.65 (-1.85%) |
| ITC | ₹413.90 | -₹7.10 (-1.69%) |
| JIO FIN SERVICES LTD | ₹294.05 | -₹1.95 (-0.66%) |
| Suzlon | ₹64.73 | -₹0.95 (-1.45%) |
| Tata Motors | ₹712.05 | -₹3.30 (-0.46%) |
| Tata Power | ₹397.20 | -₹4.45 (-1.11%) |
| Tata Steel | ₹152.13 | -₹0.76 (-0.5%) |
| Wipro | ₹260.21 | +₹0.60 (0.23%) |
| YES Bank | ₹20.16 | -₹0.26 (-1.27%) |
KILITCH DRUGS News
FAQs on KILITCH DRUGS
What is the share price of KILITCH DRUGS today?
KILITCH DRUGS share price is ₹ 454.50 as on 13 Jun, 2025 | 15:53 IST.
What are the high & low stock price of KILITCH DRUGS today?
KILITCH DRUGS stock price hit a high of ₹ 459.90 and low of ₹ 433.30 as on 13 Jun, 2025 | 15:53 IST.
What is the market cap of KILITCH DRUGS?
The market cap of KILITCH DRUGS is ₹ 730.94 Crores as on 13 Jun, 2025 | 15:53 IST.
What are the the 52-week high and low share prices of KILITCH DRUGS stock on the NSE?
52-week high stock Price of KILITCH DRUGS is ₹ 499.00 and Low Price is ₹ 299.95 as on 13 Jun, 2025 | 15:53 IST.
What are the stock symbols of KILITCH DRUGS?
The stock symbol of KILITCH DRUGS is NSE: KILITCH on the NSE, BSE: 524500 on the BSE, and the ISIN is INE729D01010.
Can I buy KILITCH DRUGS shares on Holidays?
No, shares of KILITCH DRUGS or any other publicly traded company cannot be bought or sold on holidays when the stock exchanges are closed. You can only buy or sell KILITCH DRUGS shares on days when the stock exchanges are open for trading. It's important to check the NSE & BSE holidays calendar, before placing any trades to avoid any inconvenience.
What is the PE and PB ratio of KILITCH DRUGS?
The PE and PB ratio of KILITCH DRUGS is 27.76 and 3.48 respectively, as on 13 Jun, 2025 | 15:53 IST.